Sodium‐glucose cotransporter 2 inhibitor luseogliflozin improves glycaemic control, assessed by continuous glucose monitoring, even on a low‐carbohydrate diet

Yazar: Nishimura, R., Omiya, H., Sugio, K., Ubukata, M., Sakai, S., Samukawa, Y.
Yayımlandı Diabetes Obes Metab (2016)

Carcinogenicity in mice and rats of heterocyclic amines in cooked foods.

Yazar: Ohgaki, H, Hasegawa, H, Kato, T, Suenaga, M, Ubukata, M, Sato, S, Takayama, S, Sugimura, T
Baskı/Yayın Bilgisi 1986

Effects of luseogliflozin, a sodium–glucose co‐transporter 2 inhibitor, on 24‐h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabe...

Yazar: Nishimura, R., Osonoi, T., Kanada, S., Jinnouchi, H., Sugio, K., Omiya, H., Ubukata, M., Sakai, S., Samukawa, Y.
Yayımlandı Diabetes Obes Metab (2015)